Currently Viewing:
COA 2017-ONCOLOGY PAYMENT REFORM
David Merrill and John Robinson Discuss Barriers to APMs, Factors of Interest
January 15, 2018
Dr Jeff Patton Discusses Preparing for OCM, Seeing Improved Outcomes and Savings
January 12, 2018
Dr Peter Aran on Involving Providers in Development Process of New Reimbursement Models
January 11, 2018
Sarah Cevallos on Her Advice for Practices Looking to Participate in OCM
January 10, 2018
Dr Roger Brito: What Patients Should Know About Alternative Payment Models, OCM
January 09, 2018
Dr Mark Fendrick on Indication-Based Drug Pricing in Cancer Care
January 07, 2018
Bo Gamble on COA's Role in 2018
January 05, 2018
Judy Berger on What Southwest Airlines Is Doing in Oncology
January 04, 2018
Currently Reading
Terrill Jordan Discusses Making Refinements in Year 2 of OCM
January 03, 2018
Terrill Jordan: Year 1 Feedback on OCM
December 22, 2017
Dr Lucio Gordan: Improving Population Health Through Alternative Payment Models
December 08, 2017
Dr Ira Klein on Pharmaceutical Interest in Alternative Payment Models
December 07, 2017
Dr Ira Klein Outlines the Biggest Challenge of Value-Based Drug Pricing
November 05, 2017
Stakeholders Weigh-in on Payment Reform in Cancer Care
October 25, 2017
The Commercial Payer OCM Experience: Year 1
October 25, 2017
Terrill Jordan: Education and Data Are Key for OCM Success
October 25, 2017
Physicians Need Clearer Metrics Before Taking on 2-Sided Risk
October 25, 2017
Dr Jeff Patton Highlights Challenges Encountered With Implementing OCM
October 24, 2017
Dr Lucio Gordan: How Practices and Payers Work Together to Implement OCM
October 24, 2017

Terrill Jordan Discusses Making Refinements in Year 2 of OCM

Year 2 of the Oncology Care Model is about learning from the lessons of year 1 and extending implementation that has already been started, said Terrill Jordan, CEO of Regional Cancer Care Associates.


Year 2 of the Oncology Care Model (OCM) is about learning from the lessons of year 1 and extending implementation that has already been started, said Terrill Jordan, CEO of Regional Cancer Care Associates.

Transcript

In terms of next steps, what does year 2 of OCM hold for you?

Year 2 is about extending the implementation that we’ve already started. So we’ve learned a lot over that year. We learned to prioritize a little bit more in terms of the data we need and how we prioritize the data as we deliver it to our clinicians. The education process, we’ve learned a little bit more about how we should structure the education process for our clinicians. So we’ve worked a lot on that. We’re looking at the workflow and how we can handle the workflow a little bit differently. We get the feedback now, the feedback loop is taking place. We’re learning what we didn’t do so well, we are learning what worked.

And our clinicians, I think, are a big change, our clinicians are engaging now in a way that they didn’t engage at the start. While they were intellectually engaged, they weren’t emotionally engaged. Now we are seeing emotional engagement. It’s that refining process that is starting to take place.

 
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!